[go: up one dir, main page]

DK0524180T3 - Smagsmaskering af ibuprofen ved fluid bedovertrækning - Google Patents

Smagsmaskering af ibuprofen ved fluid bedovertrækning

Info

Publication number
DK0524180T3
DK0524180T3 DK91904188.9T DK91904188T DK0524180T3 DK 0524180 T3 DK0524180 T3 DK 0524180T3 DK 91904188 T DK91904188 T DK 91904188T DK 0524180 T3 DK0524180 T3 DK 0524180T3
Authority
DK
Denmark
Prior art keywords
ibuprofen
taste masking
anesthetic
fluid
fluid anesthetic
Prior art date
Application number
DK91904188.9T
Other languages
Danish (da)
English (en)
Inventor
Robert Wu-Wei Shen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0524180T3 publication Critical patent/DK0524180T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91904188.9T 1990-04-11 1991-02-26 Smagsmaskering af ibuprofen ved fluid bedovertrækning DK0524180T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50819390A 1990-04-11 1990-04-11

Publications (1)

Publication Number Publication Date
DK0524180T3 true DK0524180T3 (da) 1995-09-04

Family

ID=24021750

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91904188.9T DK0524180T3 (da) 1990-04-11 1991-02-26 Smagsmaskering af ibuprofen ved fluid bedovertrækning

Country Status (14)

Country Link
US (1) US5552152A (ja)
EP (1) EP0524180B1 (ja)
JP (1) JPH05506011A (ja)
AT (1) ATE121619T1 (ja)
AU (1) AU639988B2 (ja)
CA (1) CA2076983A1 (ja)
DE (1) DE69109282T2 (ja)
DK (1) DK0524180T3 (ja)
ES (1) ES2071986T3 (ja)
FI (1) FI924589A7 (ja)
HU (2) HUT64220A (ja)
NO (1) NO300758B1 (ja)
RU (1) RU2101010C1 (ja)
WO (1) WO1991015194A1 (ja)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
IL135462A0 (en) * 1997-11-12 2001-05-20 Bayer Ag 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
WO2001021156A1 (en) * 1999-04-06 2001-03-29 Wm. Wrigley Jr. Company Pharmaceutical chewing gum formulations
AU771516B2 (en) 1999-04-06 2004-03-25 Laboratoires Des Produits Ethiques Ethypharm Drinkable ibuprofen pharmaceutical suspension
CA2380449A1 (en) * 1999-08-17 2001-02-22 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
BR0016236A (pt) 1999-12-09 2002-12-24 Boots Co Plc Agentes terapêuticos
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
EP1276470B1 (en) 2000-04-20 2007-05-02 Novartis AG Taste masking coating composition
RU2241451C1 (ru) * 2000-11-28 2004-12-10 Комиссарова Ирина Алексеевна Фармацевтическая композиция, ее применение и способ получения
RU2203042C2 (ru) * 2000-11-28 2003-04-27 Комиссарова Ирина Алексеевна Фармацевтическая композиция и способ ее получения
PL363679A1 (en) * 2001-05-09 2004-11-29 Bayer Healthcare Ag Novel use of 2-phenyl-substituted imidazotriazinones
JP2004537566A (ja) * 2001-08-01 2004-12-16 ブリストル−マイヤーズ　スクイブ　カンパニー 味マスキング組成物
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
NZ535455A (en) 2002-02-21 2009-08-28 Biovail Lab Int Srl Controlled release dosage forms
CO5400144A1 (es) 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
JP2007031281A (ja) * 2003-06-25 2007-02-08 Kowa Co イブプロフェン含有フィルムコーティング錠剤
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
JP2009509984A (ja) * 2005-09-29 2009-03-12 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ
US20070134493A1 (en) * 2005-12-08 2007-06-14 Kanji Meghpara Compositions and capsules with stable hydrophilic layers
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
CA2689638A1 (en) * 2007-06-13 2008-12-18 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
CA2690956C (en) * 2007-07-01 2017-01-03 Joseph Peter Habboushe Combination tablet with chewable outer layer
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
CN104105478A (zh) 2011-10-28 2014-10-15 维塔利斯公司 抗发红组合物
WO2013151754A1 (en) * 2012-04-02 2013-10-10 Teikoku Pharma Usa, Inc. Ibuprofen solid oral dosage composition comprising a methacrylic acid copolymer
US8993041B2 (en) 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
RU2576236C1 (ru) * 2014-08-22 2016-02-27 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2577689C1 (ru) * 2014-08-26 2016-03-20 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
RU2578408C1 (ru) * 2014-09-10 2016-03-27 Александр Александрович Кролевец Способ получения нанокапсул алкалоидов
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
EP3452023A1 (en) 2016-05-05 2019-03-13 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
RU2688148C1 (ru) * 2016-05-10 2019-05-20 Александр Александрович Кролевец Способ получения нанокапсул экоцида в каррагинане
CN110917165A (zh) * 2019-12-26 2020-03-27 北京鑫开元医药科技有限公司海南分公司 一种布洛芬口崩片及其制备方法
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
EP0212747B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release and immediate release
IT1214629B (it) * 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions

Also Published As

Publication number Publication date
DE69109282T2 (de) 1995-09-28
US5552152A (en) 1996-09-03
JPH05506011A (ja) 1993-09-02
NO923947D0 (no) 1992-10-09
FI924589A0 (fi) 1992-10-09
WO1991015194A1 (en) 1991-10-17
CA2076983A1 (en) 1991-10-12
AU639988B2 (en) 1993-08-12
HUT64220A (en) 1993-12-28
HU9203193D0 (en) 1992-12-28
EP0524180B1 (en) 1995-04-26
ES2071986T3 (es) 1995-07-01
EP0524180A1 (en) 1993-01-27
DE69109282D1 (de) 1995-06-01
HU211247A9 (en) 1995-11-28
AU7256091A (en) 1991-10-30
NO300758B1 (no) 1997-07-21
RU2101010C1 (ru) 1998-01-10
NO923947L (no) 1992-10-09
ATE121619T1 (de) 1995-05-15
FI924589L (fi) 1992-10-09
FI924589A7 (fi) 1992-10-09

Similar Documents

Publication Publication Date Title
DK0524180T3 (da) Smagsmaskering af ibuprofen ved fluid bedovertrækning
ATE121625T1 (de) Pharmazeutische zusammensetzung.
DE3674018D1 (de) Optische kupplungsvorrichtung.
FI923375A0 (fi) Anordning och foerfarande foer iontoforetisk transfusion.
DE69021635D1 (de) Beschichtete optische Übertragungsmedien.
DE69023342D1 (de) Optische vorrichtungen.
DE3676666D1 (de) Optische kopplungsanordnung.
NO911502D0 (no) Tilslutningslister for telekommunikasjonsteknikker.
DE69010594D1 (de) Optische Verstärker.
FI881191A0 (fi) Kompakt maskin foer framstaellning av cigarretter.
NL193153B (nl) Optische koppelinrichting.
ES513076A0 (es) "procedimiento para la polimerizacion de una 1-olefina".
FI875174L (fi) Maskin foer faellning och bearbetning av traed.
FI901443A0 (fi) Sammansaettningar och lokala foerfarande foer forming av en film pao kropps vaevande.
DE3888150D1 (de) Optische Vermittlung.
DK472182A (da) Fremgangsmaade til fremstilling af et praeparat til behandling af urinvejsinfektioner
IT8026302A0 (it) Dispositivo di fissaggio d'una lampada sul riflettore d'unproiettore.
DE68903504D1 (de) Maskenfilm.
DE69014837D1 (de) Optische Verbindungsvorrichtung.
ES515292A0 (es) "un sistema para multiplexar senales opticas".
ES511941A0 (es) "un procedimiento para la polimerizacion de un compuesto de eterglicidilico".
DK32290D0 (da) Anvendelse af 8'-acylerede derivater af mellemproduktforbindelsen mb-530a til fremstilling af et laegemiddel til behandling af hypercholesterolaemi
ES513074A0 (es) "procedimiento para la polimerizacion de una 1-olefina".
DE69015079D1 (de) Optische Multiplexierung.
FI885854L (fi) Kolv foer tryckdriven kolvmaskin.